Pharmaceutical News and Updates

EMA/HTA parallel consultation platform

On 30 June 2017 the EMA and EUnetHTA launched the new EMA/HTA parallel consultation platform. The new guidance replaces the former draft best practice guide as of publication date and has been developed from the experience gained with the SEED project, the best practice on EMA/HTA parallel advice pilot from 2010 and the subsequent public…
More

Update to Orphan Product MAA variations

  On November 18, 2016, EMA published an update to the post-authorisation guidance on MA extensions and type II variations to include further details on the information companies need to provide when submitting a Type II variation or a MA extension for an orphan-designated medicine. This follows the publication of a new…
More

The public consultation on Europe’s Paediatric Regulation

The Paediatric Regulation (Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products) was adopted in 2007 to address a serious gap in knowledge on how medicine should best be used by children. Although evidence-based proof is not disputed for…
More

Reorganisational Change at EMA

The European Medicines Agency (EMA) has announced some organisational adjustments and important strategic amendments of its corporate management structure that will result in a leaner, more streamlined architecture and improved administrative support. Building on the 2013/2014 reorganisation of the Agency, the changes fine-tune the re-engineered organisational model to further improve…
More

EMA publishes report on parallel Scientific Advice

EMA published a report on the pilot on its parallel regulatory-health technology assessment scientific advice with a Best Practice Guide. Background: Since 2010, the EMA has initiated a pilot project of parallel HTA-regulatory scientific advice, with the participation of several HTA bodies that allows developers to receive simultaneous feedback from…
More

ICH Readies new guidance

The Assembly finalised its rules of procedure, which reflect the new emphasis on clearer governance, transparency and openness in the operation of the reformed ICH, and will be published shortly. Key advances for public health ICH aims to improve health through harmonisation of global regulatory requirements. Some of the key…
More